Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0ZG3S
|
|||
| Drug Name |
Reproxalap
|
|||
| Synonyms |
2-(3-Amino-6-chloroquinolin-2-yl)propan-2-ol; 2-(3-amino-6-chloroquinolin-2-yl)propan-2-ol; Reproxalap [USAN]; UNII-F0GIZ22IJH; F0GIZ22IJH; SCHEMBL12228833; ALD-102; ADX-102; 2-Quinolinemethanol, 3-amino-6-chloro-alpha,alpha-dimethyl-; NS2
Click to Show/Hide
|
|||
| Indication | Sjogren-Larsson syndrome [ICD-11: 5C52.03] | Phase 3 | [1] | |
| Company |
Aldeyra Therapeutics Lexington, MA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H13ClN2O
|
|||
| Canonical SMILES |
CC(C)(C1=C(C=C2C=C(C=CC2=N1)Cl)N)O
|
|||
| InChI |
1S/C12H13ClN2O/c1-12(2,16)11-9(14)6-7-5-8(13)3-4-10(7)15-11/h3-6,16H,14H2,1-2H3
|
|||
| InChIKey |
GUHFUVLKYSQIOQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 916056-79-6
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Malondialdehyde (MDA) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.